Connect Biopharma Provides Business Update and Reports First Half 2021 Financial ResultsGlobe Newswire • over 2 years ago---
- "- On Track to Report CBP-201 Phase 2B Top-Line Data Evaluating Moderate-to-Severe
Atopic Dermatitis (AD) in Q4 of 2021 - - Cash Balance of RMB 2,025.0 Million (USD
313.5 Million) at June30, 2021 - SAN DIEGO, CA and TAICANG, SUZHOU, China, Aug.
31, 2021 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings ..."